usv private limited

USV is a 62 year young Indian healthcare company with pharmaceutical manufacturing & research and marketing capabilities for Pharma & Consumer business. The company started as a subsidiary of Revlon and now operates as an independent entity in domestic and international markets. Built on deeply rooted Credo values, the company is leading in therapeutic segments like Cardio and Diabetology in India. It is also significant in Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology and CNS. USV’s International business consists of a portfolio of small molecule APIs (31 of which are commercially available) and finished dosages exported to 65+ countries. It has 7 manufacturing plants across India (4 for Formulation, 2 for APIs & 1 for Biological Drugs), a Corporate office and a Research & Development Center in Mumbai with the help of 6800+ human capital. The facilities are accredited by global regulators such as USFDA, EMA, MHRA & others and are cGMP compliant. USV’s promise of being a reliable health partner to its customers and stakeholders is reflected in its leadership position in the Oral Anti-Diabetic market - ranked #1 by Rx and Value and in the Cardiovascular diseases segment - ranked #1 by Rx and #4 by Value. The company invests 3% of its revenue in R&D and has received a grant for 12 patents. USV’s Consumer Business: Sebamed is a leading Baby and Personal care brand. Other segments include Beauty, Food, and nutrition. It ranks #3 in Indian Baby care and is growing exponentially. USV lives by the culture of excellence through quality products, therapy leadership, a robust supply chain and sustainable practices & giving back to society. USV Credos: Customer Orientation, Collaboration, Commitment, Challenge, Communication, and Cheerfulness are guiding forces in how it operates.

Wockhardt Ltd.

Wockhardt is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Specialty Hospitals. Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 3000 Wockhardt Associates from 21 different nationalities globally. It has 3 research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. Headquartered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland and France. It also has its marketing presence in emerging markets of Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait. Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions people’s lives through better health. Wockhardt aspires to create a healthier world. Its strategic vision of ‘More & More with Less & Less’ has transformed into new ways of thinking, a new journey for growth, medical breakthroughs for patients and continuing value for all stakeholders.

cphi & pmec india

CPHI & PMEC India is here to enhance your business, leadership, knowledge, innovation, recognition, networking and a lot MORE in the field of Pharma.

EVERSANA

EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.

CEVA SANTE ANIMALE

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”. Our 21 R&D centers and 33 production sites worldwide attest to our commitment to research and the development of increasingly innovative solutions.  2024 turnover: €1.77 billion.